See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
American International Group, Inc. (AIG) - free report >>
AptarGroup, Inc. (ATR) - free report >>
Anika Therapeutics Inc. (ANIK) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
American International Group, Inc. (AIG) - free report >>
AptarGroup, Inc. (ATR) - free report >>
Anika Therapeutics Inc. (ANIK) - free report >>
Image: Bigstock
New Strong Sell Stocks for February 27th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
AdvanSix Inc. (ASIX - Free Report) is a manufacturer and seller of polymer resins. The Zacks Consensus Estimate for its current year earnings has been revised 3.3% downward over the last 30 days.
American International Group, Inc. (AIG - Free Report) is a provider of insurance products for commercial, institutional and individual customers. The Zacks Consensus Estimate for its current year earnings has been revised 7.7% downward over the last 30 days.
Anika Therapeutics, Inc. (ANIK - Free Report) is a provider of orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions. The Zacks Consensus Estimate for its current year earnings has been revised 1.9% downward over the last 30 days.
AptarGroup, Inc. (ATR - Free Report) is a provider of consumer dispensing, active packaging and drug delivery solutions and services. The Zacks Consensus Estimate for its current year earnings has been revised 5.4% downward over the last 30 days.
Dorman Products, Inc. (DORM - Free Report) is a provider of automotive replacement parts, automotive hardware and brake products. The Zacks Consensus Estimate for its current year earnings has been revised 8.3% downward over the last 30 days.
View the entire Zacks Rank #5 List.